Utah Medical Products Stock Analysis

Utah Stock Analysis Notes

About 69.0% of the company outstanding shares are owned by institutional investors. The company has Price to Book (P/B) ratio of 1.71. Historically many companies with similar price-to-book (P/B) ratio do better than the market in the long run. Utah Medical Products last dividend was issued on the 17th of March 2026. The entity had 3:2 split on the 22nd of March 1993. Utah Medical Products, Inc. develops, manufactures, and distributes medical devices for the healthcare industry. The company was incorporated in 1978 and is headquartered in Midvale, Utah. Utah Medical operates under Medical Instruments Supplies classification in the United States and is traded on NASDAQ Exchange. It employs 178 people. For more information please call Kevin Cornwell at 801 566 1200 or visit https://www.utahmed.com.

Utah Medical Products Investment Alerts

Utah Largest EPS Surprises

View All Earnings Estimates

Utah Medical Environmental, Social, and Governance (ESG) Scores

Utah Stock Institutional Investors

Note, although Utah Medical's institutional investors appear to be way more sophisticated than retail investors, it remains unclear if professional active investment managers can reliably enhance risk-adjusted returns by an amount that exceeds fees and expenses.

Utah Market Capitalization

The company currently falls under 'Small-Cap' category with a current market capitalization of 205.36 M.

Utah Profitablity

The company has Profit Margin (PM) of 0.29 %, which maeans that even a very small decline in it revenue will erase profits resulting in a net loss. This is way below average. Similarly, it shows Operating Margin (OM) of 0.31 %, which suggests for every 100 dollars of sales, it generated a net operating income of $0.31.

Management Efficiency

Utah Medical Products has return on total asset (ROA) of 0.0582 % which means that it generated a profit of $0.0582 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of 0.0954 %, meaning that it created $0.0954 on every $100 dollars invested by stockholders. Utah Medical's management efficiency ratios could be used to measure how well Utah Medical manages its routine affairs as well as how well it operates its assets and liabilities. As of February 17, 2026, Return On Tangible Assets is expected to decline to 0.1. In addition to that, Return On Capital Employed is expected to decline to 0.09. At present, Utah Medical's Total Current Assets are projected to increase significantly based on the last few years of reporting. The current year's Other Assets is expected to grow to 0.95, whereas Non Currrent Assets Other are projected to grow to (1.09).

Technical Drivers

As of the 17th of February 2026, Utah Medical has the Semi Deviation of 1.12, coefficient of variation of 725.15, and Risk Adjusted Performance of 0.1138. In relation to fundamental indicators, the technical analysis model makes it possible for you to check existing technical drivers of Utah Medical Products, as well as the relationship between them. Please validate Utah Medical Products treynor ratio, and the relationship between the standard deviation and downside variance to decide if Utah Medical is priced more or less accurately, providing market reflects its prevalent price of 65.68 per share. Given that Utah Medical Products has jensen alpha of 0.1667, we advise you to double-check Utah Medical Products's current market performance to make sure the company can sustain itself at a future point.

Utah Medical Products Price Movement Analysis

Utah Medical Products Insider Trading Activities

Utah Medical Outstanding Bonds

Utah Medical Predictive Daily Indicators

Utah Medical Corporate Filings

Utah Medical Forecast Models

Utah Medical's time-series forecasting models are one of many Utah Medical's stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Utah Medical's historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.

Utah Medical Bond Ratings

Utah Medical Products financial ratings play a critical role in determining how much Utah Medical have to pay to access credit markets, i.e., the amount of interest on their issued debt. The threshold between investment-grade and speculative-grade ratings has important market implications for Utah Medical's borrowing costs.

Utah Medical Products Debt to Cash Allocation

Utah Medical Products currently holds 3.27 M in liabilities with Debt to Equity (D/E) ratio of 0.0, which may suggest the company is not taking enough advantage from borrowing. Utah Medical Products has a current ratio of 13.17, suggesting that it is liquid enough and is able to pay its financial obligations when due. Note, when we think about Utah Medical's use of debt, we should always consider it together with its cash and equity.

Utah Medical Total Assets Over Time

Utah Medical Assets Financed by Debt

The debt-to-assets ratio shows the degree to which Utah Medical uses debt to finance its assets. It includes both long-term and short-term borrowings maturing within one year. It also includes both tangible and intangible assets, such as goodwill.

Utah Medical Debt Ratio

0.3

It looks as if most of the Utah Medical's assets are financed through equity. Typically, companies with high debt-to-asset ratios are said to be highly leveraged. The higher the ratio, the greater risk will be associated with the Utah Medical's operation. In addition, a high debt-to-assets ratio may indicate a low borrowing capacity of Utah Medical, which in turn will lower the firm's financial flexibility.

Utah Medical Corporate Bonds Issued

Utah Short Long Term Debt Total

Stock analysis is the technique used by a trader or investor to examine and evaluate how Utah Medical prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Utah shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Stock such as Utah Medical. By using and applying Utah Stock analysis, traders can create a robust methodology for identifying Utah entry and exit points for their positions.

When running Utah Medical's price analysis, check to measure Utah Medical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Utah Medical is operating at the current time. Most of Utah Medical's value examination focuses on studying past and present price action to predict the probability of Utah Medical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Utah Medical's price. Additionally, you may evaluate how the addition of Utah Medical to your portfolios can decrease your overall portfolio volatility.